Table 2 Patient outcomes stratified by resistance pattern of infecting organism (VRE vs. VSE) and underlying severity of illness before infection.
|  | Total (n = 50) | VSE (n = 33) | VRE (n = 17) | AP2≤18 | AP>18 |
|---|---|---|---|---|---|
Respiratory failure | 42% | 42% | 41% | 32%* | 75%* |
Cardiovascular failure | 40% | 42% | 35% | 34% | 58% |
Renal failure | 48% | 42% | 59% | 39%* | 75%* |
Hematologic failure | 44% | 33%* | 65%* | 42% | 50% |
Liver failure | 26% | 24% | 29% | 24% | 33% |
7-day mortality | 18% | 15% | 23% | 13% | 33% |
Overall mortality | 48% | 42% | 59% | 39%* | 75%* |